Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01589198 · ClinicalTrials.gov registry record
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 110
- Enrollment target
NCT01589198: Completed study, sponsored by National Jewish Health.
NCT01589198 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01589198 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about asthma in people who are not well-controlled with current asthma medication (refractory asthma). The investigators will compare data from refractory asthmatic patients here at National Jewish Health to mild asthmatics subjects and to people without asthma. Study experiments involve looking at samples from all 3 groups and comparing them at a molecular level. These laboratory experiments may help identify subtypes of refractory asthmatics that require different treatments.
Primary Outcome
Comparing invasive phenotyping to non-invasive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-06 |
What the finished NCT01589198 record still lists
NCT01589198 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01589198 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01589198 about?
NCT01589198 is a clinical study titled "Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma". The purpose of this study is to learn more about asthma in people who are not well-controlled with current asthma medication (refractory asthma). The investigators will compare data from refractory asthmatic patients here at National Jewish Health to mild asthmatics subjects and to people without as...
What is the current status of trial NCT01589198?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2012-01. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT01589198?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia